ArticleJournal of pharmacy & bioallied sciences2025
Efficacy of Integrating Immunotherapy with Surgical Resection in Oral Squamous Cell Carcinoma: A Clinical Study.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This research evaluates the efficacy of integrating immunotherapy with surgical resection in the treatment of "oral squamous cell carcinoma (OSCC)." By analyzing clinical outcomes, we aim to provide evidence for a combined therapeutic approach. Methods: A cohort of 120 OSCC patients was divided into two groups: surgical resection alone ( Results: Patients in the combined therapy group showed significantly improved three-year overall survival (78% vs. 62%) and reduced recurrence rates (15% vs. 28%). Quality-of-life scores were also higher in the immunotherapy group. Conclusion: Integrating immunotherapy with surgical resection improves clinical outcomes in OSCC, suggesting a promising direction for multimodal treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.